CETSA Hsp90i - Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.omicsdi.org/dataset/pride/PXD005508
下载链接
链接失效反馈官方服务：
资源简介：
The goal of this project is to identify the drug target of XL888, an hsp90i used in clinical trial against melanoma
创建时间：
2018-02-13
